Phoenix, Arizona is the 5th largest city in the United States and one of the fastest growing for more than 5 years. CBRE’s annual life science report ranked Phoenix 5th in the Nation among Emerging Life Science Markets and 1st in Life Science Job Growth in Emerging Life Science Markets in 2020 and 2021 respectively.
Phoenix is setting the standard for technology and precision medicine and driving translational discovery. Phoenix’s public and private Institutes of Research Excellence collaborate and leverage expertise, knowledge and skills in areas of genomics, precision medicine, new therapy development, molecular medicine, cancer, neuroscience, rare disease research, bioinformatics and artificial intelligence.
Phoenix offers a deep talent base, a critical mass of serial entrepreneurs, enterprises and globally recognized institutes of clinical excellence to turn discovery into firms and products for preventing, early detection, treating and curing disease.
Since 2019, capital investment exceeding $3.8 billion has led to almost 6 million square feet of new bioscience healthcare primary facilities. Examples of new facilities include the expansion of Bristol Myers Squibb for their biologics manufacturing facility, Caris Life Sciences new liquid biopsy laboratory, Exact Sciences, SCHOTT MiniFab, Translational Genomics Research Institute (TGen) part of City of Hope, W.L. Gore’s expansion of their medical device manufacturing facility, the Ivy Brain Tumor Center at Dignity Health’s Barrow Neurological Institute opening the world’s largest translational research center dedicated solely to brain tumor drug development and treatment.
Phoenix is home to four major hubs of biosciences - the Phoenix Cotton Center, the Phoenix Bioscience Core, Phoenix’s Central Bio-Health District and Mayo Clinic’s Discovery Oasis. Each is home to globally recognized leaders in bio and health innovation, patient care, clinical research and medical education.
Phoenix is a place where ideas are nurtured, innovation is celebrated, and new explorers are welcomed. Visit our delegation of innovators in our Phoenix Pavilion 3035 during BIO International to connect and learn more. Contact: Claudia.Whitehead@phoenix.gov www.PHXisBIO.com
Phoenix is setting the standard for technology and precision medicine and driving translational discovery. Phoenix’s public and private Institutes of Research Excellence collaborate and leverage expertise, knowledge and skills in areas of genomics, precision medicine, new therapy development, molecular medicine, cancer, neuroscience, rare disease research, bioinformatics and artificial intelligence.
Phoenix offers a deep talent base, a critical mass of serial entrepreneurs, enterprises and globally recognized institutes of clinical excellence to turn discovery into firms and products for preventing, early detection, treating and curing disease.
Since 2019, capital investment exceeding $3.8 billion has led to almost 6 million square feet of new bioscience healthcare primary facilities. Examples of new facilities include the expansion of Bristol Myers Squibb for their biologics manufacturing facility, Caris Life Sciences new liquid biopsy laboratory, Exact Sciences, SCHOTT MiniFab, Translational Genomics Research Institute (TGen) part of City of Hope, W.L. Gore’s expansion of their medical device manufacturing facility, the Ivy Brain Tumor Center at Dignity Health’s Barrow Neurological Institute opening the world’s largest translational research center dedicated solely to brain tumor drug development and treatment.
Phoenix is home to four major hubs of biosciences - the Phoenix Cotton Center, the Phoenix Bioscience Core, Phoenix’s Central Bio-Health District and Mayo Clinic’s Discovery Oasis. Each is home to globally recognized leaders in bio and health innovation, patient care, clinical research and medical education.
Phoenix is a place where ideas are nurtured, innovation is celebrated, and new explorers are welcomed. Visit our delegation of innovators in our Phoenix Pavilion 3035 during BIO International to connect and learn more. Contact: Claudia.Whitehead@phoenix.gov www.PHXisBIO.com